Nurix Therapeutics Inc To Discuss Data From The Ongoing Phase 1 Clinical Trial Transcript - Thomson StreetEvents

Nurix Therapeutics Inc To Discuss Data From The Ongoing Phase 1 Clinical Trial Transcript

Nurix Therapeutics Inc To Discuss Data From The Ongoing Phase 1 Clinical Trial Transcript - Thomson StreetEvents
Nurix Therapeutics Inc To Discuss Data From The Ongoing Phase 1 Clinical Trial Transcript
Published Jun 12, 2025
25 pages (13879 words) — Published Jun 12, 2025
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of NRIX.OQ conference call or presentation 12-Jun-25 12:00pm GMT

  
Brief Excerpt:

...Operator Welcome to the Nurix Therapeutics EHA2025 investor call. (Operator Instructions). I would now like to turn the conference over to Nurix President and CEO, Arthur Sands. Arthur, you may begin. Arthur Sands ...

  
Report Type:

Transcript

Source:
Company:
Nurix Therapeutics Inc
Ticker
NRIX.OQ
Time
12:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

Nurix Therapeutics Inc to Discuss Data Presented at ASH Transcript – 2025-12-09 – US$ 54.00 – Edited Transcript of NRIX.OQ conference call or presentation 9-Dec-25 1:15am GMT

Nurix Therapeutics Inc At Bexobrutideg Investor Update Transcript – 2025-10-22 – US$ 54.00 – Edited Transcript of NRIX.OQ corporate analyst meeting</ 22-Oct-25 12:00pm GMT

Nurix Therapeutics Inc at Morgan Stanley Global Healthcare Conference Transcript – 2025-09-10 – US$ 54.00 – Edited Transcript of NRIX.OQ presentation 10-Sep-25 11:00am GMT

Nurix Therapeutics Inc at RBC Capital Markets Global Healthcare Conference Transcript – 2025-05-21 – US$ 54.00 – Edited Transcript of NRIX.OQ presentation 21-May-25 6:05pm GMT

Nurix Therapeutics Inc Annual Shareholders Meeting Transcript – 2025-05-19 – US$ 54.00 – Edited Transcript of NRIX.OQ shareholder or annual meeting 19-May-25 4:00pm GMT

Nurix Therapeutics Inc at Barclays Global Healthcare Conference Transcript – 2025-03-12 – US$ 54.00 – Edited Transcript of NRIX.OQ presentation 12-Mar-25 2:00pm GMT

Nurix Therapeutics Inc at JPMorgan Healthcare Conference Transcript – 2025-01-13 – US$ 54.00 – Edited Transcript of NRIX.OQ presentation 13-Jan-25 11:00pm GMT

Nurix Therapeutics Inc At ASH Annual Meeting Transcript – 2024-12-09 – US$ 54.00 – Edited Transcript of NRIX.OQ conference call or presentation 9-Dec-24 4:15pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Nurix Therapeutics Inc To Discuss Data From The Ongoing Phase 1 Clinical Trial Transcript" Jun 12, 2025. Alacra Store. Nov 06, 2026. <http://www.alacrastore.com/thomson-streetevents-transcripts/Nurix-Therapeutics-Inc-To-Discuss-Data-From-The-Ongoing-Phase-1-Clinical-Trial-T16405083>
  
APA:
Thomson StreetEvents. (2025). Nurix Therapeutics Inc To Discuss Data From The Ongoing Phase 1 Clinical Trial Transcript Jun 12, 2025. New York, NY: Alacra Store. Retrieved Nov 06, 2026 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Nurix-Therapeutics-Inc-To-Discuss-Data-From-The-Ongoing-Phase-1-Clinical-Trial-T16405083>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.